MCID: CTN007
MIFTS: 57

Cutaneous Leishmaniasis malady

Infectious diseases category

Aliases & Classifications for Cutaneous Leishmaniasis

About this section

Cutaneous Leishmaniasis, Aliases & Descriptions:

Name: Cutaneous Leishmaniasis 30 9 11
Asian Desert Cutaneous Leishmaniasis 9 60
Diffuse Cutaneous Leishmaniasis 9 60
Ethiopian Cutaneous Leishmaniasis 60
 
Leishmaniasis Diffuse Cutaneous 43
Leishmaniasis, Cutaneous 60
Leishmaniasis Cutaneous 43
Leproid Leishmaniasis 9


Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Infectious diseases


External Ids:

Disease Ontology9 DOID:9111
NCIt38 C34768
SNOMED-CT55 240637006
MeSH33 D016773
ICD1025 B55.1

Summaries for Cutaneous Leishmaniasis

About this section


Disease Ontology:9 A leishmaniasis that involves skin infection caused by leishmania species, resulting in one or more cutaneous lesions.

MalaCards based summary: Cutaneous Leishmaniasis, also known as asian desert cutaneous leishmaniasis, is related to leishmaniasis and leprosy. An important gene associated with Cutaneous Leishmaniasis is MPI (mannose phosphate isomerase), and among its related pathways are IL4-mediated signaling events and Glucocorticoid receptor regulatory network. The drug meglumine and the compounds fe2+ and alpha-galactosylceramide have been mentioned in the context of this disorder. Affiliated tissues include colon, skin and t cells, and related mouse phenotypes are digestive/alimentary and immune system.

Wikipedia:63 Cutaneous leishmaniasis (also known as oriental sore, tropical sore, chiclero ulcer, or chiclero\'s... more...

Related Diseases for Cutaneous Leishmaniasis

About this section

Diseases related to Cutaneous Leishmaniasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 78)
idRelated DiseaseScoreTop Affiliating Genes
1leishmaniasis31.2PGD, IL13, SLC11A1, MT-CYB, MPI, IFNG
2leprosy31.2SLC11A1
3dermatitis30.5IFNG, IL13
4pulmonary tuberculosis30.4IFNG, SLC11A1
5lepromatous leprosy30.3LTA, IFNG
6pulmonary sarcoidosis30.2IFNG, LTA
7visceral leishmaniasis30.2LTA, SLC11A1, PGD, IFNG
8arthritis29.5IL13, FCER2, IFNG, LTA, SLC11A1
9erysipeloid10.5
10mucocutaneous leishmaniasis10.5
11blindness10.4
12granulomatous dermatitis10.3
13paronychia10.3
14iron metabolism disease10.2MT-CYB, SLC11A1
15acquired immunodeficiency syndrome10.2
16panniculitis10.2
17ptosis10.2
18spondylitis10.2
19allergic rhinitis10.2FCER2, IL13
20lipoid nephrosis10.2FCER2, IL13
21pneumonia10.2IL13, MT-CYB
22aspergillosis10.2MT-CYB, IFNG
23bronchiolitis10.2FCER2, IL13
24chronic granulomatous disease10.2IFNG, MT-CYB
25juvenile rheumatoid arthritis10.1SLC11A1, LTA
26bullous pemphigoid10.1IL13, FCER2
27rhinitis10.1FCER2, IL13
28acute graft versus host disease10.1LTA, IFNG
29toxic shock syndrome10.1IFNG, LTA
30schistosomiasis10.1IFNG, IL13
31psoriatic arthritis10.1
32chromoblastomycosis10.1
33tuberculoid leprosy10.1
34follicular mucinosis10.1
35herpes zoster10.1
36african tick-bite fever10.1
37necrobiosis lipoidica10.1
38lobomycosis10.1
39basal cell carcinoma10.1
40blepharitis10.1
41blepharoconjunctivitis10.1
42cellulitis10.1
43ectropion10.1
44elephantiasis10.1
45lagophthalmos10.1
46lupus erythematosus10.1
47lymphopenia10.1
48pericarditis10.1
49trypanosomiasis10.1
50tuberculosis10.1

Graphical network of the top 20 diseases related to Cutaneous Leishmaniasis:



Diseases related to cutaneous leishmaniasis

Symptoms for Cutaneous Leishmaniasis

About this section

Drugs & Therapeutics for Cutaneous Leishmaniasis

About this section

Drug clinical trials:

Search ClinicalTrials for Cutaneous Leishmaniasis

Search NIH Clinical Center for Cutaneous Leishmaniasis

Inferred drug relations via UMLS60/NDF-RT39:

Genetic Tests for Cutaneous Leishmaniasis

About this section

Anatomical Context for Cutaneous Leishmaniasis

About this section

MalaCards organs/tissues related to Cutaneous Leishmaniasis:

31
Colon, Skin, T cells, Eye, Brain, Monocytes, Liver, Testes, Kidney, Bone, Adipocyte, Breast, Prostate, Whole blood, Lymph node, Spleen, Pancreas, Salivary gland, Nk cells, Endothelial

Animal Models for Cutaneous Leishmaniasis or affiliated genes

About this section

MGI Mouse Phenotypes related to Cutaneous Leishmaniasis:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053818.4IL13, IFNG, FCER2, SLC11A1
2MP:00053878.1FCER2, IFNG, IL13, SLC11A1, LTA
3MP:00053977.7MPI, FCER2, IFNG, IL13, SLC11A1, LTA
4MP:00107687.6LTA, SLC11A1, IL13, IFNG, FCER2, MPI

Publications for Cutaneous Leishmaniasis

About this section

Articles related to Cutaneous Leishmaniasis:

(show top 50)    (show all 638)
idTitleAuthorsYear
1
Zosteriform cutaneous leishmaniasis. (25396096)
2014
2
Cutaneous leishmaniasis responds to daylight-activated photodynamic therapy: Proof-of-concept for a novel self-administered therapeutic modality. (25363817)
2014
3
Cutaneous Leishmaniasis Mimicking A Pyogenic Granuloma. (24923493)
2014
4
Rare variants of cutaneous leishmaniasis presenting as eczematous lesions. (25405136)
2014
5
Atypical presentation of cutaneous leishmaniasis in a renal transplant recipient successfully treated with allopurinol and fluconazole. (22750767)
2013
6
Pentalinon andrieuxii Root Extract is Effective in the Topical Treatment of Cutaneous Leishmaniasis Caused by Leishmania mexicana. (24347110)
2013
7
Clinical findings and management of imported cutaneous leishmaniasis: report of 14 cases from Austria. (23522841)
2013
8
LeishmaniaA braziliensis-Reactive T Cells Are Down-Regulated in Long-Term Cured Cutaneous Leishmaniasis, but the Renewal Capacity of T Effector Memory Compartments Is Preserved. (24303052)
2013
9
Leishmanicidal activity of amphotericin B encapsulated in PLGA-DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL/6 mice. (23891944)
2013
10
Cluster of zoonotic cutaneous leishmaniasis (Leishmania major) in European travelers returning from Turkmenistan. (24165385)
2013
11
Cutaneous leishmaniasis with unusual clinical and histological presentation: report of four cases. (23690110)
2013
12
Molecular characterization of leishmania infection from naturally infected sand flies caught in a focus of cutaneous leishmaniasis (eastern iran). (24409437)
2013
13
Simultaneous infection with Leishmania (Viannia) braziliensis and L. (V.) lainsoni in a Peruvian patient with cutaneous leishmaniasis. (23382155)
2013
14
Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis. (23390069)
2013
15
Travelers with cutaneous leishmaniasis cured without systemic therapy. (23633111)
2013
16
Sandflies (Diptera: Psychodidae) in rural and urban environments in an endemic area of cutaneous leishmaniasis in southern Brazil. (23778669)
2013
17
Cutaneous leishmaniasis in Al Hassa, Saudi Arabia: epidemiological trends from 2000 to 2010. (23790342)
2013
18
Effect of 3-alkylpyridine marine alkaloid analogues in Leishmania species related to American cutaneous leishmaniasis. (22882996)
2012
19
Distinct pattern of immunophenotypic features of innate and adaptive immunity as a putative signature of clinical and laboratorial status of patients with localized cutaneous leishmaniasis. (22823491)
2012
20
The knowledge, attitude, and prevention practices of students regarding cutaneous leishmaniasis in the hyperendemic region of the Shahid Babaie Airbase. (22022818)
2012
21
Cutaneous leishmaniasis acquired in Jura, France. (22257720)
2012
22
Correlation of clinical, parasitological and histopathological diagnosis of cutaneous leishmaniasis in an endemic region in Sri Lanka. (23292056)
2012
23
Latency time in cutaneous leishmaniasis. (21505401)
2011
24
PKCI' regulates IL-12p40/p70 production by macrophages and dendritic cells, driving a type 1 healer phenotype in cutaneous leishmaniasis. (21287553)
2011
25
First report on natural infection of Phlebotomus sergenti with Leishmania promastigotes in the cutaneous leishmaniasis focus in southeastern Tunisia. (21976566)
2011
26
Comparison of oral zinc sulfate with systemic meglumine antimoniate in the treatment of cutaneous leishmaniasis. (21747837)
2011
27
Lupoid cutaneous leishmaniasis: a case report. (22984663)
2011
28
Sand fly Surveillance within an Emerging Epidemic Focus of Cutaneous Leishmaniasis in Southeastern Iran. (22808384)
2010
29
Treatment of acute cutaneous leishmaniasis with intralesional injection of meglumine antimoniate: comparison of conventional technique with mesotherapy gun. (20883265)
2010
30
CD8+ T cells as a source of IFN-I^ production in human cutaneous leishmaniasis. (20967288)
2010
31
Comparison of three methods for diagnosis of cutaneous leishmaniasis. (22347259)
2010
32
Study of sand fly fauna in an endemic area of American cutaneous leishmaniasis and canine visceral leishmaniasis in the municipality of EspA-rito Santo do Pinhal, SALo Paulo, Brazil. (20428683)
2010
33
Cutaneous leishmaniasis of the lid: a report of nine cases. (20157413)
2010
34
Eight cases of feline cutaneous leishmaniasis in Texas. (20826847)
2010
35
Evaluation of intralesional 0.2% ciprofloxacin as a treatment for cutaneous leishmaniasis. (20214164)
2010
36
The expression of TLR2, TLR4 and TLR9 in the epidermis of patients with cutaneous leishmaniasis. (20493664)
2010
37
Chemokines and chemokine receptors coordinate the inflammatory immune response in human cutaneous leishmaniasis. (20854864)
2010
38
Molecular characterization of Leishmania species isolated from cutaneous leishmaniasis in Yemen. (20862227)
2010
39
Immunophenotypic pattern and cytokine profiles of dry type cutaneous leishmaniasis. (19566354)
2009
40
IFN-beta impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis. (19201909)
2009
41
Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab. (19556566)
2009
42
Pregnancy enhances the innate immune response in experimental cutaneous leishmaniasis through hormone-modulated nitric oxide production. (18347075)
2008
43
Evaluation of meglumine antimoniate effects on liver, kidney and pancreas function tests in patients with cutaneous leishmaniasis. (17951131)
2007
44
Ocular involvement in cutaneous leishmaniasis four cases with blepharoconjunctivitis. (15117121)
2004
45
Rhabdomyolysis induced by pentamidine (Pentacarinat) during treatment of cutaneous leishmaniasis: 2 cases]. (11937930)
2002
46
The efficacy of pentamidine combined with allopurinol and immunotherapy for the treatment of patients with diffuse cutaneous leishmaniasis. (9951957)
1999
47
In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis. (8880134)
1996
48
Anergic cutaneous leishmaniasis versus lobomycosis. (8737881)
1996
49
CD23 and IgE expression during the human immune response to cutaneous leishmaniasis: possible role in monocyte activation. (8008965)
1994
50
Tumor necrosis factor alpha (TNF-alpha) and TNF-beta and their receptors in experimental cutaneous leishmaniasis. (8132347)
1994

Variations for Cutaneous Leishmaniasis

About this section

Expression for genes affiliated with Cutaneous Leishmaniasis

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Cutaneous Leishmaniasis patients vs. healthy controls: 30 (show all 74)
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1CXCL9chemokine (C-X-C motif) ligand 9Skin+6.420.000
2CXCL10chemokine (C-X-C motif) ligand 10Skin+6.160.000
3IDO1indoleamine 2,3-dioxygenase 1Skin+5.970.000
4GZMBgranzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)Skin+5.880.000
5GBP5guanylate binding protein 5Skin+5.820.000
6GNLYgranulysinSkin+5.770.000
7MMP1matrix metallopeptidase 1 (interstitial collagenase)Skin+5.470.000
8GZMAgranzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)Skin+5.300.000
9CCL8chemokine (C-C motif) ligand 8Skin+5.010.000
10NKG7natural killer cell granule protein 7Skin+4.990.000
11GZMKgranzyme K (granzyme 3; tryptase II)Skin+4.890.000
12IGLL1immunoglobulin lambda-like polypeptide 1Skin+4.820.000
13CCL5chemokine (C-C motif) ligand 5Skin+4.780.000
14MMP3matrix metallopeptidase 3 (stromelysin 1, progelatinase)Skin+4.690.000
15CCL3L3chemokine (C-C motif) ligand 3-like 3Skin+4.670.000
16UBDubiquitin DSkin+4.670.000
17ADAMDEC1ADAM-like, decysin 1Skin+4.650.000
18EPSTI1epithelial stromal interaction 1 (breast)Skin+4.530.000
19IGJimmunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptidesSkin+4.530.000
20C1QBcomplement component 1, q subcomponent, B chainSkin+4.510.000
21GZMHgranzyme H (cathepsin G-like 2, protein h-CCPX)Skin+4.480.000
22GBP1guanylate binding protein 1, interferon-inducibleSkin+4.450.000
23AQP8aquaporin 8Colon-4.440.039
24CCL4L2chemokine (C-C motif) ligand 4-like 2Skin+4.440.000
25REG1Aregenerating islet-derived 1 alphaColon+4.420.002
26SSTsomatostatinColon-4.310.011
27FCER1GFc fragment of IgE, high affinity I, receptor for; gamma polypeptideSkin+4.290.000
28KIR2DL3killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3Skin+4.270.000
29GBP4guanylate binding protein 4Skin+4.230.000
30CD8ACD8a moleculeSkin+4.230.000
31TDO2tryptophan 2,3-dioxygenaseSkin+4.190.000
32FCGR1AFc fragment of IgG, high affinity Ia, receptor (CD64)Skin+4.170.000
33IL8interleukin 8Skin+4.130.000
34LYZlysozymeSkin+4.100.000
35PRF1perforin 1 (pore forming protein)Skin+4.030.000
36PYYpeptide YYColon-4.030.042
37CXCL2chemokine (C-X-C motif) ligand 2Colon+4.020.000
38REG1Bregenerating islet-derived 1 betaColon+3.990.008
39LAG3lymphocyte-activation gene 3Skin+3.990.000
40CYBBcytochrome b-245, beta polypeptideSkin+3.980.000
41WARStryptophanyl-tRNA synthetaseSkin+3.980.000
42CD3DCD3d molecule, delta (CD3-TCR complex)Skin+3.970.000
43IL18BPinterleukin 18 binding proteinSkin+3.960.000
44SNX10sorting nexin 10Skin+3.960.000
45SERPINA1serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1Skin+3.950.000
46RARRES3retinoic acid receptor responder (tazarotene induced) 3Skin+3.940.000
47MT1Mmetallothionein 1MColon-3.930.013
48IL1Binterleukin 1, betaSkin+3.930.000
49FCGR1BFc fragment of IgG, high affinity Ib, receptor (CD64)Skin+3.920.000
50BEST4bestrophin 4Colon-3.900.021
51LCN2lipocalin 2Colon+3.900.000
52INSL5insulin-like 5Colon-3.760.048
53REG3Aregenerating islet-derived 3 alphaColon+3.740.026
54CXCL11chemokine (C-X-C motif) ligand 11Colon+3.700.016
55CA7carbonic anhydrase VIIColon-3.630.024
56CXCL1chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)Colon+3.600.000
57SOX5SRY (sex determining region Y)-box 5Colon-3.580.001
58IGLimmunoglobulin lambda locusColon-3.530.020
59IL8interleukin 8Colon+3.500.004
60DEFA6defensin, alpha 6, Paneth cell-specificColon+3.490.029
61PIK3CGphosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gammaColon-3.420.007
62TTLL5tubulin tyrosine ligase-like family, member 5Colon-3.360.010
63VSTM2AV-set and transmembrane domain containing 2AColon-3.340.022
64TMCO5Btransmembrane and coiled-coil domains 5B, pseudogeneColon-3.240.008
65SPIBSpi-B transcription factor (Spi-1/PU.1 related)Colon-3.150.025
66SCGB2A2secretoglobin, family 2A, member 2Colon-3.150.045
67OR6A2olfactory receptor, family 6, subfamily A, member 2Colon-3.140.001
68OGNosteoglycinColon-3.060.022
69ABCA8ATP-binding cassette, sub-family A (ABC1), member 8Colon-3.060.043
70NEUROD1neuronal differentiation 1Colon-3.050.034
71S100A8S100 calcium binding protein A8Colon+3.040.017
72MROH9maestro heat-like repeat family member 9Colon-3.020.014
73BPIFCBPI fold containing family CColon-3.010.000
74WDR78WD repeat domain 78Colon-3.000.015

Search GEO for disease gene expression data for Cutaneous Leishmaniasis.

Pathways for genes affiliated with Cutaneous Leishmaniasis

About this section

Pathways related to Cutaneous Leishmaniasis according to GeneCards Suite gene sharing:

(show all 12)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.4LTA, FCER2
29.4IL13, IFNG
39.4IL13, IFNG
49.4IFNG, IL13
5
Show member pathways
9.3LTA, IFNG
6
Show member pathways
Transcription NF kB signaling pathway58
Immune response Toll like receptor TLR ligands and common TLR signaling pathway leading to cell proinflammatory response58
9.3LTA, IFNG
7
Show member pathways
IL27-mediated signaling events36
9.3IFNG, LTA
88.8LTA, IL13, IFNG
9
Show member pathways
8.8LTA, IL13, IFNG
108.8LTA, IL13, IFNG
11
Show member pathways
8.8LTA, IL13, IFNG
12
Show member pathways
8.4FCER2, IFNG, IL13, LTA

Compounds for genes affiliated with Cutaneous Leishmaniasis

About this section

Compounds related to Cutaneous Leishmaniasis according to GeneCards Suite gene sharing:

(show top 50)    (show all 66)
idCompoundScoreTop Affiliating Genes
1fe2+439.9SLC11A1, MT-CYB
2alpha-galactosylceramide439.8IL13, IFNG
3glatiramer acetate43 1210.8IL13, IFNG
4pirfenidone43 5910.8IFNG, IL13
5amphotericin b439.8IFNG, IL13
6il-12439.8IFNG, IL13
7indoleamine439.8IL13, IFNG
8nickel43 2410.7IL13, SLC11A1
96-phosphogluconate439.7PGD, MPI
10gm-csf43 2810.6IFNG, IL13
11fumarate43 1210.6IFNG, MT-CYB, MPI
12budesonide43 49 1211.6IFNG, IL13
13cellulose acetate439.6MPI, PGD
14isocitrate439.5PGD, MPI
15nadp+439.5MT-CYB, PGD
16salbutamol43 49 28 24 1213.4IL13, FCER2
17allergens439.4IL13, FCER2, IFNG
18hydrocortisone43 2 59 1212.4IL13, FCER2, IFNG
19okt3439.4FCER2, IFNG, LTA
20neopterin439.3IFNG, LTA, FCER2
21herbimycin a43 5910.3IFNG, FCER2, LTA
22sb 20358043 5910.3IL13, FCER2, IFNG
23glyceraldehyde 3-phosphate439.2PGD, MPI, MT-CYB
24il 10439.2IL13, IFNG, LTA
25pentoxifylline43 1210.2IL13, LTA, IFNG
26prednisolone43 28 1211.2LTA, IFNG, IL13
27endotoxin439.2IFNG, LTA, IL13
28rantes439.1IFNG, LTA, IL13
29fluticasone propionate43 49 59 1212.1IL13, IFNG
30indomethacin43 28 59 1212.1IL13, LTA, IFNG
31histamine43 28 2411.0IFNG, IL13, FCER2
32thymidine43 2410.0IL13, IFNG, FCER2, MT-CYB
33fmlp438.9IL13, LTA, MT-CYB, FCER2
34superoxide43 249.9MT-CYB, PGD, MPI, FCER2
35ionomycin438.8LTA, IL13, IFNG, FCER2
36calcitriol43 59 24 1211.8IL13, FCER2, IFNG, LTA
37pge2438.8LTA, FCER2, IFNG, IL13
38threonine438.8MT-CYB, LTA, FCER2, IL13
39dexamethasone43 49 28 1211.8LTA, IFNG, IL13, FCER2
40mannose438.7LTA, SLC11A1, IL13, FCER2, MPI
41lactate438.5FCER2, IL13, PGD, LTA
42retinoic acid43 249.5LTA, IL13, IFNG, FCER2
43aspartate438.5IL13, MPI, SLC11A1, PGD, MT-CYB
44oxygen43 249.5SLC11A1, MT-CYB, PGD, LTA
45serine438.4IL13, MT-CYB, LTA, FCER2, FCN2
46h2o2438.4LTA, IL13, MT-CYB, PGD
47cycloheximide438.4IL13, FCER2, IFNG, LTA, MT-CYB
48glutamate438.4LTA, IL13, MT-CYB, PGD
49glucose438.3PGD, LTA, MT-CYB, MPI
50nitric oxide43 24 129.2IFNG, LTA, SLC11A1, IL13, MT-CYB, PGD

GO Terms for genes affiliated with Cutaneous Leishmaniasis

About this section

Cellular components related to Cutaneous Leishmaniasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.0IL13, IFNG, FCER2

Biological processes related to Cutaneous Leishmaniasis according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of killing of cells of other organismGO:00517129.7IFNG, FCER2
2defense response to protozoanGO:00428329.7IFNG, SLC11A1
3positive regulation of humoral immune response mediated by circulating immunoglobulinGO:00029259.6LTA, FCER2
4protein import into nucleus, translocationGO:00000609.6SLC11A1, IFNG
5negative regulation of growth of symbiont in hostGO:00441309.4LTA, IFNG
6cellular component movementGO:00069289.4IL13, IFNG
7positive regulation of interferon-gamma productionGO:00327299.4LTA, SLC11A1
8response to lipopolysaccharideGO:00324969.1IL13, SLC11A1, LTA
9humoral immune responseGO:00069599.0LTA, IFNG

Molecular functions related to Cutaneous Leishmaniasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine activityGO:00051258.8LTA, IL13, IFNG

Products for genes affiliated with Cutaneous Leishmaniasis

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Cutaneous Leishmaniasis

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet